IP Library Granted Patent US 10,202,466
Granted Patent B2
US 10,202,466 · App. 13/792,534 · Granted Feb 12, 2019

Linked peptide fluorogenic biosensors

Inventor: Peter B. Berget (Philadelphia, PA)
Assignee: CARNEGIE MELLON UNIVERSITY
C07K16/44C12Q1/37G01N33/542G01N33/573G01N33/582
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,202,466
App. No.
13/792,534
Granted
Feb 12, 2019
Kind
B2
Abstract

Biosensors, compositions comprising biosensors, methods of producing biosensors, and methods of using biosensors are disclosed. The biosensors comprise a fluorogen-activating peptide and a blocking peptide. The fluorogen-activating peptide and blocking peptide are covalently linked through a peptide linker. The blocking peptide associates with the fluorogen-activating peptide thereby blocking an active domain of the fluorogen-activating peptide when the linker is in an unmodified state. The peptide linker may contain an amino acid sequence that is specifically recognized as a modification substrate by a cognate enzyme. The fluorogen-activating peptide and the blocking peptide at least partially disassociate when the linker is modified by an enzyme, thereby allowing the fluorogen-activating peptide to bind a cognate fluorogen and modulate a fluorescence signal.

Claims (25)

1. A biosensor comprising:

a fluorogen-activating peptide having an active domain; and

a blocking peptide linked to the fluorogen-activating peptide and positioned to block the active domain of the fluorogen-activating peptide;

wherein the fluorogen-activating peptide comprises a variable heavy chain domain of an antibody and the blocking peptide comprises a variable light chain domain of a different antibody;

wherein the blocking peptide is linked to the fluorogen-activating peptide through a cleavable peptide linker comprising an amino acid sequence recognized by a protease enzyme, wherein the blocking peptide blocks the active domain of the fluorogen-activating peptide when the peptide linker is intact and wherein the fluorogen-activating peptide and the blocking peptide at least partially disassociate when the peptide linker is cleaved; and

wherein the fluorogen-activating peptide that at least partially disassociates when the peptide linker is cleaved is able to bind to the cognate fluorogen thereby modulating a fluorescence signal of the cognate fluorogen,

wherein:

the variable heavy chain domain comprises the amino acid sequence of SEQ ID NO: 33, and the variable light chain domain comprises the amino acid sequence of SEQ ID NO: 21; or

the variable heavy chain domain comprises the amino acid sequence of SEQ ID NO: 23, and the variable light chain domain comprises the amino acid sequence of SEQ ID NO: 25.

2. The biosensor of claim 1 , wherein the fluorogen-activating peptide specifically binds to the cognate fluorogen selected from the group consisting of thiazole orange, malachite green, dimethyl indole red, and derivatives thereof.

3. The biosensor of claim 1 , wherein the peptide linker comprises an amino acid sequence that is recognized by a serine protease, a threonine protease, a cysteine protease, an aspartic acid protease, a matrix metalloproteinase, or a glutamic acid protease.

4. The biosensor of claim 1 , wherein:

the peptide linker comprises Glu Asn Leu Tyr Phe Gln Gly (SEQ ID NO:7) and is recognized by TEV protease;

the peptide linker comprises Leu Glu Val Leu Phe Gln Gly Pro (SEQ ID NO:9) and is recognized by a HRV-3C protease;

the peptide linker comprises Tyr Val Ala Asp (SEQ ID NO:11) and is recognized by a caspase 1 protease;

the peptide linker comprises Asp Glu Val Asp (SEQ ID NO:13) and is recognized by a caspase 3 protease; or

the peptide linker comprises Val Met Arg Leu Val Val (SEQ ID NO:15) and is recognized by MMP25 protease.

5. The biosensor of claim 1 , wherein the variable heavy chain domain consists of the amino acid sequence of SEQ ID NO: 33, and the variable light chain domain consists of the amino acid sequence of SEQ ID NO: 21.

6. The biosensor of claim 1 , wherein the variable heavy chain domain consists of the amino acid sequence of SEQ ID NO: 23, and the variable light chain domain consists of the amino acid sequence of SEQ ID NO: 25.

7. A composition comprising: a biosensor according to claim 1 and a fluorogen.

8. The composition of claim 7 , wherein the fluorogen is selected from the group consisting of thiazole orange, malachite green, dimethyl indole red, and derivatives thereof.

9. A method for analyzing protease enzyme activity comprising:

contacting a medium comprising an analyte protease enzyme with the composition according to claim 7 ; and

detecting a fluorescence signal produced by an interaction between the fluorogen activating peptide and the fluorogen.

10. The method of claim 9 , wherein the fluorogen is selected from the group consisting of thiazole orange, malachite green, dimethyl indole red, and derivatives thereof.

Assignments (2)
CONFIRMATORY LICENSE Recorded Jun 14, 2016
From: CARNEGIE-MELLON UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 038903/0631 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 11, 2013
From: BERGET, PETER B.
To: CARNEGIE MELLON UNIVERSITY
Reel/Frame 029960/0406 →
Continuity (3)
Continuation 12745882
Provisional Application 61005122 · Dec 3, 2007
Related Publication 20130177924A1 · Jul 11, 2013